HemaSphere
(Jun 2022)
PB2326: SAFE AND EFFECTIVE PROPHYLAXIS WITH PLASMA-DERIVED FACTOR X CONCENTRATE IN AN ELDERLY PATIENT WITH HEREDITARY FACTOR X DEFICIENCY
- H. Patel,
- S. Peltier,
- K. Clark,
- M. T. Reding
Affiliations
- H. Patel
- 1 Bio Products Laboratory Ltd. UK, Elstree, United Kingdom
- S. Peltier
- 2 University of Minnesota Medical Center, Minneapolis
- K. Clark
- 3 Bio Products Laboratory USA, Inc., Durham, United States of America
- M. T. Reding
- 2 University of Minnesota Medical Center, Minneapolis
- DOI
-
https://doi.org/10.1097/01.HS9.0000852128.95500.f1
- Journal volume & issue
-
Vol. 6
pp.
2195
– 2196
WeChat QR code